AKRO - Akero Therapeutics, Inc.
54.65
0.100 0.183%
Share volume: 15,312,254
Last Updated: 12-08-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$54.55
0.10
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 02-28-2025 | 05-12-2025 | 08-08-2025 | 11-07-2025 | |
| Assets | ||||||||
| Total Assets | 912.243 M | 865.043 M | 817.547 M | 825.886 M | 1.156 B | 1.109 B | 1.006 B | |
| Current Assets | 911.280 M | 776.010 M | 746.888 M | 770.380 M | 713.151 M | 764.600 M | 754.535 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 279.811 M | 449.839 M | 401.182 M | 402.840 M | 500.371 M | 521.866 M | 561.794 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 623.854 M | 310.355 M | 316.065 M | 340.238 M | 185.922 M | 220.449 M | 176.032 M | |
| Total Non-current Assets | 0.000 | 88.133 M | 69.824 M | 54.751 M | 442.003 M | 343.931 M | 250.490 M | |
| Property Plant Equipment | 17.000 K | 16.000 K | 15.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 946.000 K | 89.017 M | 70.644 M | 55.506 M | 442.692 M | 344.552 M | 251.042 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 912.243 M | 865.043 M | 817.547 M | 825.886 M | 1.156 B | 1.109 B | 1.006 B | |
| Total liabilities | 65.990 M | 66.976 M | 79.222 M | 75.774 M | 71.997 M | 83.333 M | 47.940 M | |
| Total current liabilities | 30.259 M | 31.174 M | 43.291 M | 39.754 M | 42.439 M | 60.401 M | 47.651 M | |
| Accounts Payable | 13.783 M | 14.568 M | 25.223 M | 9.027 M | 10.831 M | 13.249 M | 20.399 M | |
| Other liabilities | 928.000 K | 843.000 K | 808.000 K | 723.000 K | 747.000 K | 772.000 K | 289.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 34.803 M | 34.959 M | 35.123 M | 35.297 M | 28.811 M | 22.160 M | 0.000 | |
| Other liabilities | 928.000 K | 843.000 K | 808.000 K | 723.000 K | 747.000 K | 772.000 K | 289.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 846.253 M | 798.067 M | 738.325 M | 750.112 M | 1.084 B | 1.026 B | 957.637 M | |
| Common stock | 1.474 B | 1.482 B | 1.492 B | 1.575 B | 1.980 B | 1.992 B | 2.005 B | |
| Retained earnings | -627.440 M | -683.427 M | -756.132 M | -826.156 M | -896.881 M | -967.386 M | -1.049 B |